iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$3.50M
Expense Ratio	0.47%
PE Ratio	n/a
Shares Out	150,000
Dividend (ttm)	$0.10
Dividend Yield	0.43%
Ex-Dividend Date	Dec 17, 2024
Payout Ratio	n/a
1-Year Return	-8.37%

Volume	191
Open	23.42
Previous Close	23.37
Day's Range	23.42 - 23.42
52-Week Low	22.67
52-Week High	28.74
Beta	0.72
Holdings	72
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

41.89% of assets

Name	Symbol	Weight
Catalyst Pharmaceuticals, Inc.	CPRX	4.79%
PTC Therapeutics, Inc.	PTCT	4.40%
Neurocrine Biosciences, Inc.	NBIX	4.24%
Intra-Cellular Therapies, Inc.	ITCI	4.20%
argenx SE	ARGX	4.11%
Alkermes plc	ALKS	4.07%
ACADIA Pharmaceuticals Inc.	ACAD	4.06%
Biohaven Ltd.	BHVN	4.05%
SK Biopharmaceuticals Co., Ltd.	326030	3.99%
Xenon Pharmaceuticals Inc.	XENE	3.99%

Dividends

Ex-Dividend	Amount	Pay Date
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023